Skip to main content
LFSTLifeStance Health Group, Inc.Sell5.4·$8.54+0.41%
Open full analysis

LifeStance Health Group, Inc. (LFST) Stock Analysis

Breakout setup

SellModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. At $8.54, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%).

LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial... Read more

$8.54+7.6% A.UpsideScore 5.4/10#17 of 27 Medical Care Facilities
QualityF-score8 / 9FCF yield4.34%
Stop $7.95Target $9.18(analyst − 13%)A.R:R 0.5:1
Analyst target$10.55+23.5%10 analysts
$9.18our TP
$8.54price
$10.55mean
$13

Sell if holding. At $8.54, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Score 5.4/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202652d to earnings· next earnings call

Thesis

Rewards
Strong growth profile
Risks
Concentration risk — Customer: Elevance Health (15.0%)
Concentration risk — Customer: UnitedHealthcare (14.0%)
Thin upside margin: 7.6%

Key Metrics

P/E (TTM)141.7
P/E (Fwd)21.7
Mkt Cap$3.2B
EV/EBITDA35.7
Profit Mgn1.6%
ROE1.6%
Rev Growth21.2%
Beta1.19
DividendNone
Rating analysts17

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.71neutral
IV89%elevated
Max Pain$1-88.3% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHCustomerElevance Health15%
    10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'
  • HIGHCustomerUnitedHealthcare14%
    10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'

Material Events(8-K, last 90d)

  • 2026-03-11Item 5.02LOW
    Lisa Miller promoted to Chief Operating Officer and Principal Operating Officer effective March 10, 2026. Previously EVP, Practice Operations since February 2024. Internal appointment; no officer departure.
    SEC filing →
  • 2026-02-25Item 5.02LOW
    Kenneth Burdick, Executive Chairman, announced planned transition to non-executive Chairman effective March 16, 2026. Not due to disagreement with management or Board. Will participate in standard non-employee director compensation.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
0.2
Quality Rank
1.3
Growth Rank
8.9
Industry growth leader

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.7
52w Position
9.2
GatesA.R:R 0.5 < 1.5@spotExecutive change: officer departure/appointmentMomentum 6.4>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 52d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
67 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $7.24Resistance $8.62

Price Targets

$8
$9
A.Upside+7.5%
A.R:R0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! asymmetry at 0.5 (below the engine's 1.5 threshold)@spot

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-06 (52d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is LFST stock a buy right now?

Sell if holding. At $8.54, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Prior stop was $7.95. Score 5.4/10, moderate confidence.

What is the LFST stock price target?

Take-profit target: $9.18 (+7.6% upside). Prior stop was $7.95. Stop-loss: $7.95.

What are the risks of investing in LFST?

Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%); Thin upside margin: 7.6%.

Is LFST overvalued or undervalued?

LifeStance Health Group, Inc. trades at a P/E of 141.7 (forward 21.7). TrendMatrix value score: 5.6/10. Verdict: Sell.

What do analysts say about LFST?

17 analysts cover LFST with a consensus score of 4.1/5. Average price target: $11.

What does LifeStance Health Group, Inc. do?LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed...

LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial in-network payors and 5% from government payors.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · UHS (Universal Health Services, Inc.) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent)
Home Stocks LFST

Latest news

Latest News

GlobeNewswire47d ago
The Motley Fool47d ago
HarianBasis.co47d ago
Yahoo Finance48d ago
Zacks Investment Research33d ago
Yahoo Finance33d agoEarnings
Yahoo Finance33d ago
Investing.com India40d agoEarnings
StockStory41d agoEarnings
Investing.com48d ago
TipRanks48d ago
StockStory48d ago
Simplywall.st48d ago
Investing.com34d ago
Yahoo Finance34d ago
Yahoo Finance46d ago
Investing.com32d ago
Investing.com32d ago
Stock Titan32d ago
Stock Titan32d ago
Loading more...